← Open Payments lookup

STEVE YANG: Open Payments

NPI 1770070781 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,271 in 96 payments from 12 companies in 2025. Trend: 2023 $2,870 · 2024 $3,189 · 2025 $2,271

Food & beverage: $2,271
CompanyPaymentsAmount
Alkermes, Inc.17$469
Vanda Pharmaceuticals Inc.12$379
Neurocrine BioSciences, Inc.18$302
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)15$247
Teva Pharmaceuticals USA, Inc.8$241
E.R. Squibb & Sons, L.L.C.9$199
Otsuka America Pharmaceutical, Inc.10$198
Gilead Sciences, Inc.1$121
Axsome Therapeutics, Inc.2$41
ABBVIE INC.2$31

Products named: ARISTADA, HETLIOZ, INGREZZA, CAPLYTA, COBENFY, REXULTI, UZEDY, Yeztugo.

Industry payments across CA — which companies pay providers there.